0068-0597-01 · Rifampin Injection · Sanofi-Aventis U.S. LLC
What is the status for 0068-0597-01 · Rifampin Injection · Sanofi-Aventis U.S. LLC?
For 0068-0597-01, generic name is Rifampin Injection; manufacturer is Sanofi-Aventis U.S. LLC; status is Current; availability now is Unavailable; fda note is Discontinuation of the manufacture of the drug, recorded from its source on 2026-11-04.
"initial_posting_date": "02/17/2021", "package_ndc": "0068-0597-01", "generic_name": "Rifampin Injection", "related_info_link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Rifampin%20Injection&st=d", "contact_info": "800-633-1610", "availability": "Unavailable", "related_info": "Discontinuation of the manufacture of the drug"
— api.fda.gov, retrieved 2026-11-04
- Package NDC
- 0068-0597-01 verified
- Generic name
- Rifampin Injection verified
- Manufacturer
- Sanofi-Aventis U.S. LLC verified
- Status
- Current verified
- Availability now
- Unavailable verified
- FDA note
- Discontinuation of the manufacture of the drug verified
- Initial posting date
- 02/17/2021 verified
- Last update date
- 09/18/2026 verified
- Days in shortage
- 2086 our reading
- Reason for shortage
- Discontinuation of the manufacture of the drug verified
- Dosage form
- Injection verified
- Therapeutic category
- Anti-Infective verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Manufacturer, Status, Last update date, Reason for shortage, Dosage form and Therapeutic category
"update_date": "09/18/2026", "therapeutic_category": [ "Anti-Infective" ], "dosage_form": "Injection", "presentation": "Rifadin, Injection, 600 mg (NDC 0068-0597-01)", "company_name": "Sanofi-Aventis U.S. LLC", "shortage_reason": "Discontinuation of the manufacture of the drug", "status": "Current"
— all from api.fda.gov, retrieved 2026-11-04
Source
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sanofi-Aventis%20U.S.%20LLC%22+AND+generic_name%3A%22Rifampin%20Injection%22+AND+status%3A%22Current%22&limit=1000